When companies use Liquent for their SPL services, the Liquent team of regulatory experts uses proprietary technologies to quickly convert their labels into the standard format. Once converted and checked for accuracy, companies can go through their normal quality assurance and approval cycles.
“The U.S. pharmaceutical industry and the FDA are both moving rapidly to make professional labeling for prescription products available electronically to practitioners to facilitate access to the very latest prescribing information to promote greater patient safety,” says Dave Duplay, Thomson executive vice president. “SPL readies Thomson for timely introduction of this important advance in drug information technology.”
Thomson Scientific & Healthcare is part of The Thomson Corp. For more information, visit www.thomson.com.
Add new comment